May 12, 2021 – Leoni AG continues positive trajectory in the first quarter of 2021, which saw the initial WCS carve-out achieved. 

“We continued our operational recovery of the preceding quarters in the first quarter of 2021,” stated Leoni AG CEO Also Kamper. “We reached initial milestones in the improvement of our portfolio with the sale of Leoni Schweiz AG as well as the agreement on the disposal of business units of Leoni Kerpen GmbH. Overall, our progress in operational and strategic terms gives us confidence that we have embarked on the right course to stabilise our business on a sustainable basis. Our focus continues to be on diligently implementing all measures needed to further improve LEONI’s performance and efficiency in the future.” He cited the following positive news.

• Consolidated sales well up on the previous year in the first quarter of 2021

• EBIT before exceptional items as well as before VALUE 21 costs was, with earnings of €39 million, up substantially from the level of same quarter of the previous year (a loss of € 7 million) thanks to a sales increase and operational improvements

• Resolute implementation of our VALUE 21 performance and strategy programme; about €600 million of the gross cost savings potential realised as of 31 March 2021

• As expected, negative free cash flow of € 100 million substantially below the previous year’s neutral figure, which benefited considerably at the time from sale-and-leaseback transactions; free cash flow in the first quarter of 2021 was weighed down by the trend in net working capital related to the operational recovery

• Progress made with respect to strengthening our portfolio by having closed the sale of the first WCS unit, namely LEONI Schweiz AG, at the end of March 2021

• Agreement signed with a consortium of buyers on sale of LEONI Kerpen GmbH’s low-margin business units based in Stolberg; more than 160 jobs could be saved by continuing to operate these units in the hands of new owners at the site

• Sales and earnings outlook for fiscal 2021 raised: despite the persisting Covid-19 pandemic and bottlenecks in our global supply chains, outlook for Group sales now lifted to a significant increase (previously only a low double-digit percentage range); EBIT before exceptional items as well as before VALUE 21 costs should also improve significantly and now reach at least the break-even point